A recent study published in the New England Journal of Medicine has revealed that treating bacterial vaginosis (BV) as a sexually transmitted infection (STI) can significantly improve cure rates among women. Researchers at Monash University and Alfred Health, led by Professor Catriona Bradshaw and Dr. Lenka Vodstrcil, found that simultaneously treating both partners in monogamous relationships achieves higher cure rates than the current practice of only treating women.
The study, which involved 164 couples with BV, showed that partner treatment resulted in a halved recurrence rate compared to treating women alone. The researchers recommend treating male partners simultaneously, using an oral antibiotic and topical cream for one week, as part of a comprehensive approach to preventing BV recurrence.
Professor Bradshaw explained that previous studies had raised questions about the role of men in transmitting BV, but the new trial provides conclusive evidence that reinfection from partners is a significant cause of BV recurrence. The researchers believe that advances in genomic sequencing will help identify the exact bacteria responsible for BV in the future.
The study’s findings have already led to changes in clinical practice at the Melbourne Sexual Health Center, where partner treatment is now recommended as part of standard care. A new website provides detailed information on treating and preventing BV, designed in collaboration with consumers, participants, and health professionals.
Source: https://medicalxpress.com/news/2025-03-sti-impacts-women-reveals-men.html